Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-000604
Filing Date
2025-01-03
Accepted
2025-01-03 17:46:04
Documents
1
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form4-01032025_100101.html 4  
1 form4-01032025_100101.xml 4 3284
  Complete submission text file 0001415889-25-000604.txt   5018
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Issuer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ADHEREX TECHNOLOGIES INC. 4620 CREEKSTONE DRIVE, SUITE 200 DURHAM NC 27703
Business Address
Raykov Rosty (Reporting) CIK: 0001468316 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32295 | Film No.: 25508193